May 24, 2022
Posted May 24, 2022
Dr. Roger Wang will pay over $1 million for violations of the False Claims Act committed by charging Medicare for non-FDA-approved drugs and associated services. Dr. Wang, a rheumatology specialist, injected his patients with drugs like Synvisc, Synvisc One, or Orthovisc—vicosupplements used to treat osteoarthritis pain—that were not FDA-approved for distribution in the US, and therefore not billable to Medicare. USAO NDCA
Tagged in: Drug Switching, FCA Federal, Healthcare Fraud, Medicare, Off-Label and Unapproved Use, Provider Fraud,